Press Releases on November 12, 2019 - EIN Presswire - Press Release Distribution Service

Published on November 12, 2019 - 21:01 GMT

Allakos Reports Third Quarter 2019 Financial Results

REDWOOD CITY, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell related diseases, today reported financial results for …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

SemiLEDs to Announce Fiscal Fourth Quarter and Fiscal Year End 2019 Financial Results on Thursday, November 14, 2019

HSINCHU, Taiwan, Nov. 12, 2019 (GLOBE NEWSWIRE) -- SemiLEDs Corporation (NASDAQ:LEDS), will report financial results for the 2019 fiscal Fourth quarter and Fiscal year ended August 31, 2019 and outlook for the fiscal first quarter 2020 after market close …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 12, 2019 - 21:01 GMT

Cara Therapeutics to Present at November Investor Conferences

STAMFORD, Conn., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

Aclaris Therapeutics to Present at Upcoming Investor Conferences

WAYNE, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that management will present at the following conferences: Dr. Neal …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, Nov. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, …

Distribution channels: Business & Economy, Technology ...

Published on November 12, 2019 - 21:01 GMT

BBQ Holdings, Inc. Reports Results for Third Quarter of Fiscal 2019

MINNEAPOLIS, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating owner and operator of barbeque restaurants, globally, today reported financial results for the third fiscal quarter ended September 29, 2019. …

Distribution channels:

Published on November 12, 2019 - 21:01 GMT

Satsuma Pharmaceuticals Reports Third Quarter 2019 Financial and Business Results

Completed upsized initial public offering of $90.8 million in gross proceeds Dosed first patient in Phase 3 EMERGE™ efficacy trial of STS101 for the acute treatment of migraine Presented STS101 Phase 1 trial results and other STS101 data at medical …

Distribution channels:

Published on November 12, 2019 - 21:01 GMT

ChromaDex Corporation Reports Third Quarter 2019 Financial Results

Third Quarter 2019 Highlights vs. Third Quarter 2018 Strong growth in net sales to $12.1 million, improved gross margin, and significantly improved marketing efficiency year-over-year. TRU NIAGEN net sales of $9.7 million, an 11% increase sequentially and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

Kiniksa Presents Preclinical Data on the Role of GM-CSF in GCA at the 2019 ACR/ARP Annual Meeting

- Mavrilimumab suppresses pathogenic immune responses in a validated in vivo model of medium and large vessel vasculitis - - Additional human ex vivo data support rationale for targeting GM-CSF in GCA - HAMILTON, Bermuda, Nov. 12, 2019 (GLOBE NEWSWIRE) -- …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

Nabriva Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

-More than 200 hospital formulary reviews of XENLETA™ scheduled before the end of the year- -Approximately 50% of all covered lives have outpatient formulary access to XENLETA- -Initiating focused community sales efforts for XENLETA- -Conference call today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2019

Company to host R&D Day on January 28, 2020, in New York GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of …

Distribution channels:

Published on November 12, 2019 - 21:01 GMT

Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

XHANCE net revenue grew 30% to $8.7 million from second to third quarter 2019 XHANCE prescriptions increased 27% from second to third quarter 2019 Company expects XHANCE net revenues for 2019 to be in the range of $30 - $33 million Conference call and …

Distribution channels:

Published on November 12, 2019 - 21:01 GMT

BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations

BELBUCA® Net Sales Increased by 115% versus Prior Year to All-time High of $26.5 Million Raises Full Year 2019 Total Company Net Sales Expectations to $105 - $110 Million Provides Full Year 2020 BELBUCA Net Sales Expectations of $150 - $160 Million and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

Aptinyx Reports Third Quarter 2019 Financial Results and Highlights

Initiated two Phase 2 studies of NYX-2925 in chronic pain conditions On track to have four Phase 2 studies ongoing by year end across pipeline of CNS product candidates Conference call today at 5:00 p.m. EST EVANSTON, Ill., Nov. 12, 2019 (GLOBE NEWSWIRE) …

Distribution channels: Business & Economy, Technology ...

Published on November 12, 2019 - 21:01 GMT

HTG Molecular Diagnostics Reports Third Quarter 2019 Results

Product and product-related services revenue increased by 228% and 125% in the three and nine-month periods, respectively, compared to the prior year periods Call scheduled for today, November 12, at 4:30pm ET TUCSON, Ariz., Nov. 12, 2019 (GLOBE NEWSWIRE) …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:01 GMT

Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock

PLANO, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 2,000,000 shares of its Class A common stock …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 12, 2019 - 21:01 GMT

BioCryst Commences Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today that it is offering to sell $55 million of its common stock in an underwritten public offering. As part of this offering, BioCryst …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 12, 2019 - 21:01 GMT

Amdocs Limited Reports Fourth Quarter Fiscal 2019 Results

Record Quarterly Revenue of $1.03 Billion Expects Fiscal 2020 Revenue Growth of 2.0%-6.0% YoY in Constant Currency Signs Strategic Multi-Year Managed Services Agreement with AT&T Quarterly Cash Dividend to be Raised From $0.285 to $0.3275 Per Share …

Distribution channels: Business & Economy, IT Industry ...

Published on November 12, 2019 - 21:01 GMT

Merus Announces Financial Results for the Third Quarter 2019 and Provides Business Update

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage company developing innovative, full-length bispecific antibodies (Biclonics®), today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 21:00 GMT

argenx announces closing of global offering

Regulated information – Inside information November 12, 2019 - 10:00 PM CET Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based …

Distribution channels: Media, Advertising & PR, Technology ...